Adtalem Global Education (NYSE:CVSA – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.
Several other research analysts have also recently weighed in on CVSA. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Wednesday, August 19th. Truist Financial cut Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 target price on the stock. in a research note on Thursday, September 3rd. Finally, Barrington Research reaffirmed an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, June 8th. One equities research analyst has rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Adtalem Global Education currently has a consensus rating of “Hold” and a consensus target price of $155.00.
View Our Latest Research Report on Adtalem Global Education
Adtalem Global Education Trading Up 0.0%
Adtalem Global Education (NYSE:CVSA – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. The firm had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. As a group, research analysts forecast that Adtalem Global Education will post 9 EPS for the current fiscal year.
Insider Buying and Selling at Adtalem Global Education
In other news, SVP Douglas Beck sold 4,526 shares of the stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $135.81, for a total transaction of $614,676.06. Following the completion of the transaction, the senior vice president directly owned 28,544 shares in the company, valued at $3,876,560.64. This represents a 13.69% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Stephen Beard sold 3,545 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $130.34, for a total value of $462,055.30. Following the completion of the transaction, the chief executive officer owned 415,197 shares of the company’s stock, valued at $54,116,776.98. The trade was a 0.85% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 22,462 shares of company stock valued at $3,027,792. Corporate insiders own 2.50% of the company’s stock.
Institutional Investors Weigh In On Adtalem Global Education
A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management bought a new stake in Adtalem Global Education Inc. (NYSE:CVSA – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors.
About Adtalem Global Education
Adtalem Global Education Inc is a provider of postsecondary education and professional training focused primarily on healthcare and other workforce-oriented fields. Through its academic institutions, the company offers degree programs, certificates and other educational services designed to prepare students for careers in nursing, medicine, veterinary medicine, public health, business and related disciplines.
Adtalem’s education network includes Chamberlain University, Walden University, Ross University School of Medicine, Ross University School of Veterinary Medicine and the American University of the Caribbean School of Medicine.
See Also
- Five stocks we like better than Adtalem Global Education
- NVIDIA Just Named AI’s Next Bottleneck—And These 3 Stocks Sit Right In It
- Gold Has Gone Sideways, But These 3 Stocks Haven’t
- The AI Bottleneck Is Not Chips Anymore and 3 Pipeline Stocks Are Cashing In
- These 3 Stocks Under $20 Have Wall Street Looking Past the Share Price
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
